Videos

Primary care dementia program adds community health workers to streamline screening, workups, and family guidance for earlier Alzheimer’s care.

Demonstration projects testing AI for prescription renewals and certain dental diagnoses have been approved by Utah's Office of Artificial Intelligence Policy.

The state of Oregon has a commitment to keeping people covered and created a bridge program that extended Medicaid eligibility, Hunter noted.

Shorter hospital stays are a "good barometer" for quality and patient experience, says Risant Health CEO Jaewon Ryu.

The need for translation and navigation services — the staffing to support them has increased, says Hunter, particularly in immigration communities.

Smile Digital Health’s Intelligence Hub operationalizes computable clinical knowledge into measurable outcomes. Learn how payers and providers use unified data, digital HEDIS, and guideline-driven intelligence to close care gaps, reduce friction, and deliver real ROI.

As Smile Digital Health enters its 10th year, CEO Duncan Weatherston shares why 2026 marks a strategic shift from data interoperability to unified data and intelligence. Discover how Smile Omni transforms fragmented systems into computable, actionable healthcare ecosystems.

HHS Secretary Robert F. Kennedy Jr.’s vaccine policies, the federal government shutdown, most-favored-nation drug pricing and the future of Medicare Advantage were among the topics discussed by a panel of Washington, D.C., healthcare policy professionals during a Managed Healthcare Executive webinar. Ryann Hill, M.P.H., of Indigo Hill Strategies; Patrick Cooney of The Federal Group; and Lindsay Greenleaf, J.D., MBA, of ADVI Health, provided insights and observations about the Trump administration’s approach to healthcare and drug pricing policy. Peter Wehrwein, managing editor of Managed Healthcare Executive, moderated the discussion.

The costs are high, and the care system is designed for episodic intervention, “but then what happens?" asks Hunter.

Risant Health comprises Geisinger Health in Pennsylvania and Cone Health in North Carolina. Risant CEO Jaewon Ryu, M.D., J.D., discussed how the two systems are prime candidates for adopting value-based care practices

James Ellison, M.D., M.P.H., and IBX’s Rodrigo Cerdá, M.D., M.P.H., back Jefferson Health primary care screening to catch dementia care needs early and coordinate support.

Jaewon Ryu, M.D., J.D., sees prevention and early recognition of disease as central to value-based care practices and programs at health systems.

Jaewon Ryu, M.D., J.D., CEO of Risant Health, discusses the role of accountable care organizations in supporting value-based practices at health systems.

Zahra Mahmoudjafari shares how The University of Kansas Cancer Center builds sustainable cell and gene therapy programs amid new CMS access rules.

In the first segment of a video interview with MHE, the CEO of Risant Health discusses the role of scale in following value-based practices.

Early pharmacy leadership helps health systems build safe, sustainable cell and gene therapy programs, aligning contracts, workflows, regulations and payer realities.

Health systems learn why cell and gene therapy success depends on workflows, staffing, and finances—not just science—and how to build them.

In this video interview, Joseph Kleiman, president of Buzz Health, says that patients should always “do their homework” to see if they are paying the lowest possible price for their prescription, whether that’s through TrumpRx or another website.

Jessica Vazzaz, a doctoral researcher and tutor in psychology at the University of Sussex, shared that health plans should require large, well-designed randomized trials before covering sonic sleep aids. She added that benefits are likely fair and could vary by individual, making it critical to understand who these tools actually help and under what conditions.

GLP-1 drugs boost health but challenge plastic surgery as rapid weight loss triggers facial sag and skin changes, prompting new options and lifestyle guidance.

Clinicians weigh sonic sleep tools: who benefits, how to use phone-based audio safely and why CBT-I stays first-line for insomnia.

GLP-1 weight-loss drugs can trigger facial fat loss, deepening wrinkles and sagging; experts warn appearance concerns may reduce adherence and affect health outcomes.

Recent research compares sleep aids in apps—sonic sleep sounds, white noise and pink noise—and warns weak evidence may waste money and delay proven insomnia care.

Patients using GLP-1 medications may notice facial changes due to fat loss. Vasyukevich stresses education and options for maintaining a youthful appearance.